This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Total anomalous pulmonary venous connection (TAPVC)


1. History

Total anomalous pulmonary venous connection (TAPVC) is a congenital heart malformation in which all the pulmonary veins connect to systemic veins or the right atrium rather than the left atrium. It was first described by Wilson in 1798 in an autopsy report, and until the early 20th century it was known only from autopsy findings.

Clinical surgical treatment began in earnest after Lewis and colleagues achieved the first successful surgical repair using hypothermia in 1956. In 1962, Cooley and Ochsner reported repair using cardiopulmonary bypass. Surgical approaches were refined through the 1970s~1980s, and as the occurrence of pulmonary vein obstruction (pulmonary vein stenosis, PVS) came to be recognized as a major complication, surgical techniques were improved.

Among the surgical innovations to reduce pulmonary vein stenosis complications, the most important was the introduction of the sutureless technique (pericardium-in-situ repair), and since the 2000s excellent results have been reported in cases with severe pulmonary vein stenosis or recurrent stenosis. In Korea as well, the sutureless technique has been actively applied at major centers since the 2010s.

2. Causes

The cause of TAPVC arises from the process of pulmonary vein development in the embryonic period.

In normal development, around 4~5 weeks of gestation the primitive common pulmonary vein arises from the posterior wall of the left atrium and connects with the splanchnic plexus of the lungs. The left atrium then absorbs the common pulmonary vein, so that the individual pulmonary veins connect directly to the left atrium.

TAPVC is known to occur when this absorption process fails or when the primitive pulmonary vein maintains its connection with systemic veins (supracardiac type: SVC, left superior vena cava, right-sided veins; cardiac type: coronary sinus, right atrium; infracardiac type: portal vein, hepatic veins, IVC; mixed type) instead of the left atrium.

The Darling classification (1957) remains the standard classification in use today:

3. Genetics

The genetics of TAPVC differs according to the presence of associated malformations.

Heterotaxy-related:

Isolated sporadic TAPVC:

Turner syndrome (45,X):

When TAPVC is diagnosed, whether heterotaxy syndrome is suspected is assessed, and when complex malformations accompany it, chromosomal microarray and a cardiovascular genetic panel test are considered.

4. General epidemiology

TAPVC shows a moderate frequency among congenital heart malformations.

Pulmonary vein obstruction (obstructed TAPVC) differs by type:

In Korea it is eligible for special copayment reduction V150, and several hundred cases are diagnosed each year. Treatment is provided at specialized pediatric cardiac surgery centers.

5. Pathophysiology

The key point of the pathophysiology of TAPVC is that, because all the pulmonary veins connect to systemic veins or the right atrium, the pulmonary and systemic circulations must be connected at the atrial level (atrial septal defect or patent foramen ovale) in order to survive.

Basic hemodynamics:

Obstructed TAPVC:

Unobstructed TAPVC:

6. Symptoms

The symptoms of TAPVC differ greatly depending on the presence of obstruction and the type.

Obstructed TAPVC (obstructed type, mainly infracardiac type):

Unobstructed TAPVC (unobstructed type, mainly supracardiac and cardiac types):

Even in unobstructed TAPVC, if left untreated, pulmonary vascular obstructive disease progresses and the opportunity for surgery may be lost.

7. Signs

Physical examination findings in patients with TAPVC:

Common findings:

Heart murmurs by type:

Characteristic chest X-ray findings:

ECG: right ventricular hypertrophy (right axis deviation, right ventricular hypertrophy pattern in V1), P wave abnormalities.

Echocardiography: the common venous chamber behind the left atrium, right heart dilation, left heart findings, and the direction of flow across the atrial septal defect are confirmed.

8. Screening

Screening tests for early detection of TAPVC:

Prenatal ultrasound:

Neonatal pulse oximetry:

Suspected association with heterotaxy syndrome:

9. Diagnosis

Tests used for diagnosis and preoperative evaluation of TAPVC:

Echocardiography:

Cardiovascular CT angiography (CTA):

Cardiac MRI/MRA:

Cardiac catheterization:

10. Treatment

Treatment of TAPVC is complete surgical repair, and the timing is decided by the presence of obstruction.

Obstructed TAPVC: neonatal emergency surgery

Surgical methods:

Unobstructed TAPVC: elective surgery is performed as early as possible (within several weeks after diagnosis). Correction before pulmonary vascular disease progresses is important.

TAPVC with heterotaxy syndrome: the surgical plan varies with the complexity of the associated malformations, and single-ventricle palliation is often required.

11. Prognosis

The surgical prognosis of TAPVC has continued to improve.

Operative mortality:

Long-term survival:

Major long-term complication: pulmonary vein stenosis (PVS)

Other complications: arrhythmia (atrial fibrillation, atrial flutter), recurrence of atrial septal defect, right heart dysfunction.

12. Prevention

There is no established method of preventing the occurrence of TAPVC. Strategies to improve prognosis are as follows.

Enhanced prenatal diagnosis:

Prevention and early detection of pulmonary vein stenosis:

Genetic counseling:

Prevention of respiratory infection: because respiratory infection before and after surgery can cause clinical deterioration, infection prevention measures are taken, including RSV prophylaxis (high-risk infants during the RSV season).

13. References

  1. Darling RC, et al. Total pulmonary venous drainage into the right side of the heart: report of 17 autopsied cases not associated with other major cardiovascular anomalies. Lab Invest. 1957;6(1):44-64. PMID:13413123
  2. Lupinetti FM, et al. Total anomalous pulmonary venous connection: repair by sutureless technique. Ann Thorac Surg. 1993;55(5):1219-1223. PMID:8488439
  3. Hancock Friesen CL, et al. Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg. 2005;79(2):596-606. PMID:15680839
  4. Photiadis J, et al. Sutureless repair of total anomalous pulmonary venous connection. Eur J Cardiothorac Surg. 2008;34(4):883-887. PMID:18640050
  5. Bando K, et al. Surgical management of total anomalous pulmonary venous connection: 30 years of experience. Circulation. 1996;94(9 Suppl):II12-16. PMID:8901722
  6. Michielon G, et al. Total anomalous pulmonary venous connection: long-term appraisal with evolving technical solutions. Eur J Cardiothorac Surg. 2002;22(2):184-191. PMID:12142185
  7. Jenkins KJ, et al. Threshold for reporting congenital cardiac defects in infancy: the Baltimore-Washington Infant Study. Am J Epidemiol. 1995;141(9):789-797. PMID:7741122
  8. Seale AN, et al. Total anomalous pulmonary venous connection: outcome of postoperative pulmonary venous obstruction. J Thorac Cardiovasc Surg. 2013;145(4):1083-1090. PMID:22677155
  9. Karamlou T, et al. Outcomes after late reoperation in patients with repaired total anomalous pulmonary venous connection. Ann Thorac Surg. 2007;84(3):873-878. PMID:17720393
  10. Yanagawa B, et al. Sutureless repair for pulmonary vein stenosis-midterm results. J Thorac Cardiovasc Surg. 2014;147(1):279-287. PMID:23962567